the role of mrd in clinical decision-making in r/r cll
Published 1 year ago • 99 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
1:19
the prognostic value of mrd in cll
-
1:39
the growing role of mrd as a clinical endpoint in cll
-
1:59
the expanding role of mrd in cll
-
2:34
real-world data and mrd in cll
-
25:43
the liver's vital role part1
-
26:34
chronic lymphocytic leukemia: mrd updates
-
2:40
willis: clonoseq for determining response in lymphoid cancers
-
1:37
the importance of genomic testing in the diagnosis of cll
-
2:54
clonoseq: evaluating mrd in cll
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
3:25
measuring mrd in cll
-
0:36
the use of ai for analyzing genetic and molecular data in cll
-
0:44
the clinical meaning of mrd below the threshold of mcr in aml
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
3:05
mrd assessment in cll
-
2:13
cll at a genomic level
-
6:28
prognostic markers and mrd in cll
-
1:01
cll resistance mechanisms in the era of novel agents
-
2:34
sequencing of therapies in patients with r/r cll